¤ô½_ | Âø³§@ª« | ½µæ | ªG¾ð | ªá¥c | ¯S¥Î§@ª« | ¨ä¥L |
¯f®`Ãþ
¤@¡N¤ô½_½_¼ö¯fTF-156¡]´I¦Ì¼ö´µ¡^50%²V¦XWP
Âή`Ãþ
¤@¡N¤ô½_½Å¸½¾imidacloprid¡]¯q¹FÓi¡^9.6% SL
¤G¡N¤ô½_´³¸½¾CONFIDOR¡]¯q¹FÓi¡^9.6% SL
Âø¯óÃþ
¤@¡N¤ô¥ÐÂø¯óimazosulfuron¡]¨Ì³t¶©¡^10% SC
Âø¯óÃþ
¥Íªø½Õ¸`¾¯
¯f®`Ãþ
¤@¡N¤Q¦rªá¬ì]¥ß¬\¯fpencycuron¡]»«§J¶©¡^23.2% SC
¤G¡N¬v»¥Ê½¯¬\¯fpolyoxin B + thiophanate methyl¡]«O²É«O²b¡^
¤T¡N¬v»¥Ê½¯¬\¯fTOPSIN-M¡]¥Ò°ò¦h«O²b¡^3% PASTE
¥|¡NµfX²Óµß©Ê´³ÂI¯f¹Å½ç»É81.3% WP
¤¡N²¢´Ô²Óµß©Ê´³ÂI¯fkasugamycin + copper oxychloride¡]¹Å½ç»É¡^81.3% WP
Âή`Ãþ
¤@¡N¥ÌÂŤpµæ¸¿bensultap¡]§K³t¹F¡^50% WP
¤G¡N¥ÌÂŤpµæ¸¿REGENT¡]ªâ´¶¥§¡^4.95% SC
¤T¡B½µæµfX´³¼çÃÇ
- ªü¤Ú¥Å2% EC
- §G¸ªQ43% EC
¥|¡N«C½µ²¢µæ©]¸¿CONFIRM 19.7% SC
Âø¯óÃþ
¯f®`Ãþ
¤@¡NÂcªG¥Õ¯»¯fcarbendazim + imazalil¡]¨©ªâ¨Ì·À¦C¡^40% WP
¤G¡NÂcªG¥Õ¯»¯fVECTRA¡]·Í§J®y¡^8.93% SC
¤T¡N¸²µå¥Õ¯»¯fANVIL-MILCURB SUPER¡]¨Ì·çµá§J§Q¡^17.9% SC
¥|¡N¤ì¥Ê¬´¯j¯f¥Ò°ò¾N¤D®ú70% WP
¤¡N¯ïªKÅS¬Ì¯f¹Å½ç¨©ªâ¡]¬ü¨¦¤¦¡^43% WP
Âή`Ãþ
¤@¡N¯ïªK¸¦³EÂΡ]¥i¥i²Ó¸¿¡^ DECIS¡]²Ä·À¹ç¡^2.4% SC
¤T¡NªJªI¸蟎
- ²¦¹F¥»20% WP
- ·s±þ蟎25% EC
Âø¯óÃþ
Âή`Ãþ
Âή`Ãþ
¤@¡N¯ù¯«¿A¤ó¸蟎milbemectin 1% EC
¯ó¥ÖÂø¯ó
¯f®`Ãþ
¤@¡N¤ô½_½_]®{ªø¯fHEALTHIED 20% WP
¤T¡N¤ô½_¯¾¬\¯fCH0493-A 34.5% WP
¥|¡N¤ô½_½uÂÎ¥Õ¦y¯f
- fenamiphos¡]ªâ·ÀªQ¡^40% EC¡A10% GR
- oxamyl¡]¼Þ±þ·À¡^24% SL¡A10% GR
¤»¡N¬v»¥Ê¥Õ¯»¯fFOLICUR¡]±o§J§Q¡^23.8% EC
¤C¡N¬v»¥Ê½¯¬\¯fSPORGON¡]¼³§J©Ô¿ø¡^50% WP
¤K¡N¬v»¥ÊÅSµß¯fCUPROXAT¡]¤T¤¸²¸»Ä»É¡^27.12% SC
¤E¡NµfX²Óµß©Ê´³ÂI¯f¹Å½ç»É81.3% WP
¤Q¡N´µæ¨ªùׯf
¤T±oªâ84.2% EC ¤T±o¹ç30% EC µá§J§Q5% SC ¤Q¤@¡NªøÓÞ¨§¥Õ¯»¯f
¤Q¤G¡N¸²µå¶Âµk¯fCUPROXAT¡]¤T¤¸²¸»Ä»É¡^27.12% SCTOPAS¡]¥§J®y¡^10.5% EC BAYFIDAN¡]¤T®õ¶©¡^5% WP SCORE¡]«Ý§J§Q¡^24.9% EC ¤Q¤T¡N¸²µå¶Âµk¯f»Gµ´§Ö±o¹ç53% WP
¤Q¥|¡N±ù¶Â¬P¯fCH0493-A 34.5% WP
¤Q¤¡N±ù¶Â¬P¯fFROWNCIDE 50% SC
¤Q¤»¡N±ù½ü¯¾¯f
- fenarimol¡]ªâ·ç²ö¡^11.76% EC
- carbendazim + iprodione¡]¨©ªâ¦P¡^50% WP
- thiabendazole¡]»Gµ´¡^40% WP
¤Q¤C¡N±ù¥®]¥Õ¯¾¦Ð¯f¨È½ç®E40% WP
¤Q¤K¡N®çùׯf
- µá§J§Q5% SC
- §J¼ö²b25%SL
- ¤T®õ¶©23% EC
- ¤T®õªâ5% WP
- ¤ñ¦h¹A28% EC
¤Q¤E¡N¦L«×´Ç¥Õ¯»¯f
- ÁÚ§J¥§40% WP
- Áɺֹç18.6% EC
- Å@ª¿±o37% EC
- ¤ñªâ¿Õ20.8% EC
- ¥§J®y10.5% EC
- µá§J§Q5% SC
¤G¤Q¡N¬U¨¤´³¯f
¤G¤Q¤@¡N«D¬wµâ¬Ì¯f
- myclobutanil¡]ÁÚ§J¥§¡^40% WP
- ·À¹F¼Ö5% GR
- ºÖÁɱo80% WP
- ¤T¤¸²¸»Ä»É27.12%SC
- ¨ÈÁC»Ä
Âή`Ãþ
¤@¡N¤ô½_½Å¸½¾cartap + imidacloprid¡]¯q¹F°ö¤¦¡^50% + 6% WP
¤T¡N¤ô½_´³¸½¾cartap + imidacloprid¡]¯q¹F°ö¤¦¡^50% + 6% WP
¥|¡N¤ô½_½F³¥¿Á¡]Áa±²¸ÂΡ^ cartap¡]°ö¤¦¡^6% GR
¤¡N¤ô½_½F³¥¿Á¡]Áa±²¸ÂΡ^ cartap + imidacloprid¡]¯q¹F°ö¤¦¡^50% + 6% WP
¤»¡N¥ÌÂŤpµæ¸¿Ä¬¤Oµß¡]¦h¤OÄ_¡^32000IU/mg WP
¤C¡N¥ÌÂů¾¥Õ½ºchlorpyrifos¡]³³´µªQ¡^50% WP
¤K¡N¥ÌÂů¾¥Õ½ºKAYAPHOS + cypermethrin¡]¥[Å@ªQ¡ÏÁÉ·À¹ç¡^30% EC
¤E¡N«C½µ²¢µæ©]¸¿CONFIRM 19.7% SC
¤Q¤@¡N¬a®Ü¸蟎¹F°¨ªâ´¶¹ç45% EC
¤Q¤G¡N¬a®Üù×蟎·s±þºÖ¤Æ§Q50% EC
¤Q¤T¡N»¿¼ªáÁª°¨chlorpyrifos¡]³³´µªQ¡^5% GR
¤Q¥|¡Nµf¯ïªKÁª°¨carbosulfan¡]¤B°ò¥[«O§ß¡^40% WP
¤Q¤¡NªJªIªÞ蟎¥[«O§Q85% WP
¤Q¤»¡N¦L«×´Ç¸ÂÍMARSHAL¡]¤B°ò¥[«O§ß¡^40% WP
¤Q¤C¡Nµâªá´Ö°Hcartap + imidacloprid¡]¯q¹F°ö¤¦¡^50% + 6% WP
Âø¯óÃþ
¤@¡N¤ô¥ÐÂø¯óWOLF-TN¡]±þ¤¦§K³t¶©¡^5.1% GR
¤T¡Nªá¥Í¥Ð¥Ý¥»¬ìÂø¯ósethoxydim¡]¦è±þ¯ó¡^12.5% EC